Antares Pharma Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
20,506.80
35,151.70
20,658.80
24,338.80
16,743.00
6,515
Depreciation, Depletion & Amortization
493.30
1,224.20
1,569.80
1,860.70
2,104.00
2,724
Other Funds
104.30
154.40
-
83.60
249.00
6,720
Funds from Operations
14,928.30
27,692.70
14,609.00
18,936.00
11,466.00
10,511
Changes in Working Capital
39.90
1,359.40
13,677.60
3,741.00
11,628.00
6,811
Net Operating Cash Flow
14,968.20
26,333.30
28,286.60
15,194.90
23,094.00
17,322
Capital Expenditures
3,163.60
5,653.10
6,686.70
5,006.70
1,268.00
Sale of Fixed Assets & Businesses
-
-
-
-
1,901.00
Purchase/Sale of Investments
2,870.50
24,000.00
9,037.70
15,000.00
4,964.00
Net Investing Cash Flow
293.10
18,346.90
15,724.30
9,993.30
4,331.00
Issuance/Reduction of Debt, Net
-
-
-
-
24,706.00
Net Financing Cash Flow
2,222.50
2,950.70
42,881.50
17.50
26,273.00
Net Change in Cash
13,029.80
5,038.30
1,130.20
5,184.10
1,153.00
Free Cash Flow
17,711.40
30,996.60
33,929.70
20,074.50
24,261.00
Change in Capital Stock
2,326.80
3,105.10
42,881.50
101.10
1,816.00
Exchange Rate Effect
8.90
2.60
0.70
0.10
1.00
About Antares Pharma
View Profile
